Format

Send to

Choose Destination
Stem Cell Res. 2019 Apr 2;37:101422. doi: 10.1016/j.scr.2019.101422. [Epub ahead of print]

Generation of induced pluripotent stem cell line-NTUHi001-A from a premature ovarian failure patient with Turner's syndrome mosaicism.

Author information

1
Graduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan.
2
Bioresource Collection and Research Center, Food Industry Research and Development Institute, Hsinchu, Taiwan.
3
Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan.
4
Graduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan. Electronic address: hfchen@ntu.edu.tw.

Abstract

Turner's syndrome (TS) is one of the main causes of premature ovarian failure (POF). However, the mechanisms underlying POF are difficult to study due to the lack of suitable disease models. Herein, we have generated a human induced pluripotent stem cell (hiPSC) line derived from the peripheral blood mononuclear cells of a female patient with Turner's syndrome mosaicism via integration-free Sendai-virus system. The hiPSCs were confirmed with a 45, X karyotype and the acquisition of pluripotency. It's likely that hiPSCs can serve as a feasible cellular model for further pathophysiological studies of POF cases, especially for those originating in TS.

PMID:
31004936
DOI:
10.1016/j.scr.2019.101422
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center